Vincerx Pharma, Inc. VINC
0.02
0.00
0.00%
as of 24 Sep
- Market cap
- $250.0K
- P/E
- 0.0×
Follow VINC
Growth Flags
show if company had growth for consecutive years
| Jan '19 | Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.00 | 0.00 | 1.67 | 1.67 | 8.04 | 8.04 | 6.11 | 6.11 | 2.63 | 1.21 |
Net Debt/EBITDA |
0.00 | 0.00 | 5.77 | 5.78 | 1.79 | 1.79 | 0.75 | 0.74 | 0.30 | 0.17 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.00 | 0.00 | 0.14 | 0.14 | 0.85 | 0.85 | 0.91 | 0.95 | 1.01 | 0.87 |
Capex/Depreciation |
— | — | — | 0.00 | 0.00 | (15.46) | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 103.45% | 103.45% | (131.20%) | (65.49%) | (62.54%) | (39.18%) | (88.34%) | (132.13%) | (136.38%) | (431.29%) | |
| (9,000.00%) | (9,000.00%) | (52.60%) | (26.30%) | (43.46%) | (33.40%) | (73.88%) | (106.24%) | (103.63%) | (229.38%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
102.27% | 102.27% | (65.70%) | (65.70%) | (38.50%) | (40.04%) | (130.61%) | (134.05%) | (433.99%) | (2,663.77%) |
Average Days of Receivables |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | — | 0.00% | — | 0.00% | — | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
0.00 | 0.00 | (0.16) | (8.68) | (1.94) | (45.02) | (2.83) | (56.68) | (37.98) | (13.77) |
Cash per Share |
0.00 | 0.00 | 4.42 | 235.31 | 6.50 | 129.91 | 2.50 | 49.96 | 12.07 | 2.67 |
Shareholders Equity per Share |
(0.01) | (0.20) | 1.81 | 96.65 | 5.84 | 116.82 | 2.27 | 45.33 | 10.54 | 1.44 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.01) | (0.20) | 1.81 | 96.65 | 5.84 | 116.82 | 2.27 | 45.33 | 10.54 | 1.44 |
Free Cash Flow |
— | 0.00 | (2.28) | (2.28) | (33.40) | (38.66) | (59.60) | (59.60) | (40.45) | (26.13) |
Working Capital |
(0.04) | (0.04) | 25.30 | 25.30 | 97.92 | 97.92 | 46.81 | 46.81 | 9.13 | 1.13 |
Capital Expenditures |
— | — | — | 0.00 | (0.26) | (5.26) | — | — | — | — |
Net Current Asset Value |
(0.04) | (0.04) | 25.30 | 25.30 | 94.49 | 94.49 | 44.35 | 44.35 | 7.74 | 1.13 |
| Other line items | ||||||||||
Quick Ratio |
0.00 | 0.00 | 1.63 | 1.63 | 8.02 | 8.02 | 5.89 | 5.89 | 2.48 | 1.16 |
Depreciation/Fixed assets |
— | — | — | 0.00 | 0.08 | 1.46 | 0.29 | 3.66 | 2.28 | 0.00 |
Cash ROIC |
0.00% | 0.00% | (2.61%) | (2.61%) | (17.74%) | (15.87%) | (62.72%) | (59.66%) | (168.54%) | (335.39%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | 0.00 | — | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | 0.00 | — | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
0.00 | 0.00 | (0.16) | (8.68) | (1.94) | (38.89) | (2.83) | (56.68) | (37.98) | (13.77) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (6.12) | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | — | — | 1.37 | 1.21 | 1.04 |
Average Payables |
0.04 | 0.04 | 2.76 | 2.99 | 1.26 | 2.02 | 2.54 | 3.57 | 3.28 | 2.26 |
Average Assets |
0.00 | 0.00 | 31.60 | 63.19 | 90.43 | 117.68 | 88.48 | 59.29 | 38.75 | 13.11 |
Average Common Equity |
(0.04) | (0.04) | 12.67 | 25.38 | 62.85 | 100.32 | 73.99 | 47.67 | 29.45 | 6.97 |
Capex to Sales |
— | — | — | 0.00 | — | 0.00 | — | — | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates